## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract; no access to full manuscript, figures, tables, or supplementary materials
- **Shared manuscript claim summary** The authors use deep learning methods, primarily AlphaFold, to predict interactions between the human Mediator complex subunit MED25 ACID domain and transactivation domains (TADs). They report that predictions for the H1 interface align well with experimental data, while H2 interface predictions are inconsistent. They experimentally validate predictions for two viral activators, Lana-1 and IE62. They also report a unique hydrophobic pocket predicted for the Arabidopsis MED25 ACID domain.
- **Visible evidence base** Abstract text only; no experimental details, prediction scores, or structural comparisons are provided
- **Missing materials affecting confidence** Full manuscript, methods, figures, tables, supplementary data, and any statistical or structural validation details

## Reviewer
- **Overall assessment** The abstract presents a potentially useful benchmarking study of AlphaFold for MED25 TAD interactions, with a clear distinction between reliable and unreliable interface predictions. However, the abstract alone provides insufficient detail to evaluate the rigor of the experimental validation, the basis for the Arabidopsis claim, or the broader significance of the findings. The work may interest structural biologists and computational biologists, but the current evidence base is too thin to establish the case.
- **Who would be interested in the results, and why** Structural biologists studying transcriptional regulation and Mediator complex interactions, computational biologists developing or benchmarking protein-protein interaction prediction methods, and researchers working on viral activators that target MED25. The comparison of AlphaFold predictions against experimental data is directly relevant to those assessing the utility of deep learning in structural biology.
- **Major strengths** The study addresses a timely question about the reliability of deep learning predictions for a biologically important interaction. The explicit comparison of two binding interfaces on the same domain provides a useful internal control. The inclusion of experimental validation for two viral activators strengthens the practical relevance.
- **Major Concerns**  
  - **Concern ID** R1-M1  
  - **Severity** Major  
  - **Blocking** Yes  
  - **Axis** Evidence sufficiency  
  - **Claim pointer** The abstract claims that AlphaFold predictions for the H1 interface "agree well with experimental data" and that H2 interface predictions are "inconsistent, preventing reliable binding modes."  
  - **Evidence pointer** Abstract only; location not provided  
  - **Concern** The abstract provides no quantitative or qualitative details on how agreement or inconsistency was assessed. No metrics, confidence thresholds, or comparison methods are described.  
  - **Why it matters** Without a defined criterion for "agreement" or "inconsistency," the central claim of the study is not verifiable. The reader cannot judge whether the conclusions are robust or based on subjective interpretation.  
  - **Resolution test** Provide specific metrics (e.g., interface RMSD, contact overlap, confidence scores) and a clear threshold for agreement, with corresponding figures or tables in the full manuscript.  
  - **Concern ID** R1-M2  
  - **Severity** Major  
  - **Blocking** Yes  
  - **Axis** Experimental validation rigor  
  - **Claim pointer** The abstract states that the authors "experimentally assess the validity of MED25 interface predictions with the viral transcriptional activators Lana-1 and IE62."  
  - **Evidence pointer** Abstract only; location not provided  
  - **Concern** No experimental method is specified (e.g., mutagenesis, binding assays, structural determination). The nature and extent of the validation are unclear.  
  - **Why it matters** Experimental validation is a key strength claimed by the authors, but without method details, the reader cannot assess whether the validation is sufficient to support the predictions.  
  - **Resolution test** Describe the experimental approach, the specific predictions tested, and the results in the full manuscript, with appropriate controls and replicates.  
  - **Concern ID** R1-M3  
  - **Severity** Major  
  - **Blocking** Yes  
  - **Axis** Claim support  
  - **Claim pointer** The abstract claims that AlphaFold predictions "suggest the existence of a unique hydrophobic pocket for the Arabidopsis MED25 ACID domain."  
  - **Evidence pointer** Abstract only; location not provided  
  - **Concern** The basis for this claim is not described. No comparison to known structures, sequence analysis, or experimental evidence is provided.  
  - **Why it matters** This is a novel structural claim that extends beyond the human MED25 focus. Without supporting evidence, it appears speculative and may distract from the main findings.  
  - **Resolution test** Provide structural analysis, comparison to homologous domains, or experimental data that substantiates the uniqueness and functional relevance of the pocket.
- **Minor Comments**  
  - **Concern ID** R1-m1  
  - **Severity** Minor  
  - **Axis** Clarity  
  - **Affected element** Abstract scope  
  - **Evidence pointer** Abstract  
  - **Issue** The abstract shifts from human MED25 to Arabidopsis MED25 without clear motivation or context.  
  - **Required correction** Clarify why the Arabidopsis domain was included and how it relates to the human MED25 findings.  
  - **Concern ID** R1-m2  
  - **Severity** Minor  
  - **Axis** Terminology  
  - **Affected element** "unique hydrophobic pocket"  
  - **Evidence pointer** Abstract  
  - **Issue** The term "unique" is ambiguous and could imply either a novel structural feature or a pocket not found in other species.  
  - **Required correction** Define "unique" in the context of the comparison and specify the reference set.  
  - **Concern ID** R1-m3  
  - **Severity** Minor  
  - **Axis** Completeness  
  - **Affected element** Methods description  
  - **Evidence pointer** Abstract  
  - **Issue** The abstract does not specify which deep learning methods were used beyond AlphaFold, despite the phrase "deep learning methods" in the first sentence.  
  - **Required correction** List all methods compared and briefly state their roles in the study.
- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3. The abstract does not provide sufficient evidence to establish the reliability of the H1 predictions, the validity of the experimental validation, or the basis for the Arabidopsis claim.

## Risk / unsupported claims
- The claim that H1 interface predictions "agree well with experimental data" is unsupported without defined metrics or thresholds.
- The claim that H2 interface predictions are "inconsistent" is unsupported without a clear comparison framework.
- The claim of experimental validation for Lana-1 and IE62 is unverifiable without method details.
- The claim of a "unique hydrophobic pocket" in Arabidopsis MED25 is unsupported and appears speculative from the abstract alone.

## Assessment against Nature-style criteria
- **Originality** The study addresses a relevant question about the applicability of AlphaFold to a specific protein interaction system, but the abstract does not demonstrate a novel conceptual advance beyond benchmarking.
- **Scientific importance** The findings could inform the use of AlphaFold for transcriptional regulation studies, but the significance is not clearly articulated in the abstract.
- **Interdisciplinary readership** The topic bridges structural biology and computational biology, but the abstract is too brief to engage a broad audience.
- **Technical soundness** Not assessable from the abstract; the lack of methodological detail prevents evaluation.
- **Readability for nonspecialists** The abstract is concise and generally clear, but terms like "H1 and H2 interfaces" and "ACID domain" assume prior knowledge.

## Recommendation posture
Currently not established from the provided evidence. The abstract presents a plausible study, but the absence of methodological and quantitative detail means the core claims cannot be evaluated. A full manuscript with detailed methods, results, and validation would be required to assess whether the case is made.